Earnings Call · Q1 FY2026·2026-05-12

Q1 26EPS +6.65%·Rev n/aQ4 25EPS -92.98%·Rev n/aQ3 25EPS +36.00%·Rev n/aQ2 25EPS +5.62%·Rev n/a⚠ consensus missing

ARVINAS, INC. ARVN

Jeff Boyle — Head of Investor Relations

Randy Teel — President and CEO

Noah Berkowitz — Chief Medical Officer

Angela Cacace — Chief Scientific Officer

Andrew Saik — Chief Financial Officer

−0.9%1d on move date−0.8% vs SPY3d−2.5%5d−9.1%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ARVN calls or request research access.

More ARVN calls Browse calls Request research access